Respiratory Antigen Multiple Test Kit (SARS-CoV-2/RSV/FluA+B)
One sample. Four respiratory targets. Rapid, convenient testing at home.
Respiratory Infections Can Look Similar. Testing Can Provide Clarity.
Respiratory infections caused by SARS-CoV-2, respiratory syncytial virus (RSV), and influenza A and B viruses can produce similar symptoms, including fever, cough, sore throat, fatigue, and nasal congestion. During periods when multiple respiratory viruses are circulating simultaneously, symptoms alone may not be sufficient to distinguish between different infections.
Influenza and RSV can cause significant illness, particularly among infants, young children, older adults, and other vulnerable populations, while COVID-19 continues to contribute to the global burden of respiratory disease. Because different respiratory pathogens may require different approaches to clinical management and infection control, timely testing can provide useful information to support appropriate next steps.
For individuals experiencing respiratory symptoms, access to convenient and reliable testing can help provide additional information about the potential cause of illness and support communication with healthcare professionals when further medical advice is needed.
Multiplex Respiratory Testing from a Single Sample
The NOVAtest® Respiratory Antigen Multiple Test Kit (SARS-CoV-2/RSV/FluA+B) is a rapid immunochromatographic in vitro diagnostic test designed for the qualitative detection of antigens associated with SARS-CoV-2, respiratory syncytial virus (RSV), influenza A, and influenza B from a single anterior nasal specimen.
The test integrates four respiratory pathogen targets into one testing platform, providing a convenient alternative to performing multiple individual tests. Designed for self-testing at home, the NOVAtest® enables users to perform respiratory pathogen testing without requiring laboratory equipment or a conventional healthcare facility for the initial test procedure.
Comprehensive 4-in-1 Respiratory Pathogen Detection
The NOVAtest® simultaneously targets SARS-CoV-2, RSV, influenza A, and influenza B in a single testing process. Multiplex detection provides broader respiratory pathogen coverage than single-target testing and can help reduce the need for multiple individual tests.
One test. Four targets. One testing process.
Convenient Self-Testing at Home
The test is designed for self-testing outside traditional laboratory settings, allowing users to collect an anterior nasal specimen and perform the test at home according to the Instructions for Use.
The straightforward workflow is intended to make respiratory pathogen testing more accessible while reducing the need for an initial visit to a healthcare facility solely for testing.
Rapid Results for Timely Decisions
The NOVAtest® is designed to provide results within 15-20 minutes, enabling users to obtain timely information about the presence of targeted respiratory viral antigens.
Rapid access to test information may support decisions regarding further medical consultation, infection-control precautions, and appropriate follow-up.
Reliable Test Performance
The NOVAtest® has been evaluated for its analytical and clinical performance in accordance with applicable regulatory requirements. The product demonstrates high clinical sensitivity and specificity across the four target pathogens, supporting reliable detection when the test is used according to its intended use and Instructions for Use.
Supports More Informed Respiratory Health Decisions
Identifying the potential respiratory pathogen can provide useful information for users and healthcare professionals when considering appropriate next steps.
The test is intended to provide diagnostic information—not to replace professional medical evaluation or clinical judgment.
Respiratory viruses frequently circulate at the same time and may cause overlapping symptoms. A testing approach that considers multiple pathogens simultaneously can provide a broader perspective than testing for a single target alone.
By combining four commonly encountered respiratory pathogens in one self-testing platform, NOVAtest® is designed to make respiratory antigen testing more comprehensive, convenient, and accessible.
SARS-CoV-2 | RSV | Influenza A | Influenza B
For complete information regarding intended use, specimen collection, testing procedures, performance characteristics, limitations, and result interpretation, please refer to the product's Instructions for Use.
Ordering Information
| Cat. No | Product Name | Specimen | Format | Kit Size |
|---|---|---|---|---|
| C2134-CRF-01 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/RSV/FLU A+B) | Nasal Swab | Multiple Cassette | 1T |
| C2134-CRF-02 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/RSV/FLU A+B) | Nasal Swab | Multiple Cassette | 2T |
| C2134-CRF-03 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/RSV/FLU A+B) | Nasal Swab | Multiple Cassette | 5T |
| C2134-CRF-04 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/RSV/FLU A+B) | Nasal Swab | Multiple Cassette | 20T |
| C2134-CF-01 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/FLU A+B) | Nasal Swab | Multiple Cassette | 1T |
| C2134-CF-02 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/FLU A+B) | Nasal Swab | Multiple Cassette | 2T |
| C2134-CF-03 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/FLU A+B) | Nasal Swab | Multiple Cassette | 5T |
| C2134-CF-04 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/FLU A+B) | Nasal Swab | Multiple Cassette | 20T |
| C2134-CR-01 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/RSV) | Nasal Swab | Multiple Cassette | 1T |
| C2134-CR-02 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/RSV) | Nasal Swab | Multiple Cassette | 2T |
| C2134-CR-03 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/RSV) | Nasal Swab | Multiple Cassette | 5T |
| C2134-CR-04 | Respiratory Antigen Multiple Test Kit (SARS-CoV-2/RSV) | Nasal Swab | Multiple Cassette | 20T |
| C2134-RF-01 | Respiratory Antigen Multiple Test Kit (RSV/FLU A+B) | Nasal Swab | Multiple Cassette | 1T |
| C2134-RF-02 | Respiratory Antigen Multiple Test Kit (RSV/FLU A+B) | Nasal Swab | Multiple Cassette | 2T |
| C2134-RF-03 | Respiratory Antigen Multiple Test Kit (RSV/FLU A+B) | Nasal Swab | Multiple Cassette | 5T |
| C2134-RF-04 | Respiratory Antigen Multiple Test Kit (RSV/FLU A+B) | Nasal Swab | Multiple Cassette | 20T |
Related Products
SARS-CoV-2/RSV/FluA+B Antigen Multiple Test Kit
NOVAtest® SARS-CoV-2/RSV/FluA+B Multiple Test Kit is an in vitro immunodiagnostic assay for the qualitative detection of 4 key respiratory pathogens’ antigens in nasopharyngeal swabs.
SARS-CoV-2/ RSV/Adenovirus/FluA+B Antigen Multiple Test Kit
NOVAtest® SARS-CoV-2/RSV/Adenovirus/FluA+B Antigen Multiple Test Kit is an in vitro immunodiagnostic assay for the qualitative detection of 5 key respiratory pathogens’ antigens in nasopharyngeal swabs.
SARS-CoV-2/RSV/ Adenovirus/MP/FluA+B Antigen Multiple Test Kit
NOVAtest® SARS-CoV-2/RSV/Adenovirus/MP/FluA+B Antigen Multiple Test Kit is an in vitro immunodiagnostic assay for the qualitative detection of 6 key respiratory pathogens’ antigens in nasopharyngeal swabs.